Angiotensin-Converting Enzyme 3D structures

3D Structures of Angiotensin-Converting Enzyme

Updated on 04-June-2020

{"openlevels":0}

• Angiotensin Converting Enzyme
  • 1o8a – hANCE - human
    
  • 2iul, 2iux, 3nxq, 4c2n, 4c2o, 4c2q, 4c2r – hANCE (mutant)
    
  • 2c6f – hANCE N domain
    
  • 2x8y – DmANCE – Drosophila melanogaster
    
  • 6s1y – moANCE N domain - mosquito
    
• Angiotensin Converting Enzyme N domain (1-641) complex
  • 2c6n, 1o86, 4c2p, 2ydm, 1uze, 1uzf, 6h5x - hANCE + anti-hypertensive drug
    
  • 6en5, 6en6, 4bzr, 6tt4 - hANCE + inhibitor
    
  • 4bzs, 6tt3 – hANCE (mutant) + inhibitor
    
  • 6f9r, 6f9t, 6f9u, 6f9v - hANCE + chronic heart failure drug
    
  • 3kbh, 3d0g, 3d0h, 3d0i, 2ajf, 3sci, 3scj, 3sck, 3scl, 6cs2, 6acg, 6acj, 6ack, 6lzg, 6m0j, 6vw1 – hANCE 2 + spike glycoprotein
    
  • 4bxk, 4ca5, 4ca7, 4ca8, 2xy9, 2xyd – hANCE + phosphinic inhibitor
    
  • 4ca6, 6tt1 - hANCE N domain (mutant) + phosphinic inhibitor
    
  • 4aph – hANCE + angiotensin II
    
  • 4apj, 6qs1 – hANCE + bradykinin-potentiating peptide B
    
  • 1r42, 1r4l – hANCE + disordered segment of collectrin homology domain
    
  • 2xhm – DmANCE+K inhibitor
    
  • 2x8z, 2x90, 2x91, 2x92, 2x93, 2x94, 2x95, 2x96, 2x97, 1j36, 1j37, 1j38, 3zqz – DmANCE+anti-hypertensive drug
    
  • 4aa1 – DmANCE + angiotensin II
    
  • 4aa2, 4asr – DmANCE + bradykinin-potentiating peptide B
    
  • 4asq – DmANCE + bradykinin peptide
    
  • 6s1z – moANCE + fosinoprilat
    
• Angiotensin Converting Enzyme C domain (642-1232) complex
  • 3l3n – hANCE+LISW
    
  • 3bkk, 3bkl – hANCE+ketone inhibitor
    
  • 2oc2, 4ca5, 4ca7, 4ca8 - hANCE+phosphinic inhibitor
    
  • 6h5w - hANCE (mutant) + anti-hypertensive drug
    
• Angiotensin Converting Enzyme complex
  • 6m1d – hANCE 2 + Na-dependent neutral amino acid transporter – Cryo EM
    
  • 6m17, 6m18 – hANCE 2 + Na-dependent neutral amino acid transporter + spike glycoprotein – Cryo EM
    

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Joel L. Sussman